Dr. Agarwal's Health Care Limited (BOM:544350)

India · Delayed Price · Currency is INR

497.20

+13.80 (2.85%)

At close: Jul 13, 2026

14.95% (1Y)

Market Cap	152.64B +18.4%
Revenue (ttm)	20.80B +21.6%
Net Income	1.33B +59.6%
EPS	4.18 +50.4%
Shares Out	n/a
PE Ratio	114.61
Forward PE	82.53
Dividend	n/a
Ex-Dividend Date	n/a

Volume	16,850
Open	470.45
Previous Close	483.40
Day's Range	470.45 - 502.00
52-Week Range	402.10 - 567.80
Beta	n/a
Analysts	Buy
Price Target	545.00 (+9.61%)
Earnings Date	Aug 3, 2026

About Dr. Agarwal's Health Care

Dr. Agarwal's Health Care Limited operates eye hospitals in India and internationally. It offers cataract surgeries, such as small incision cataract surgery, phacoemulsification, robotic cataract surgery, and glued intraocular lens treatments; and refractive surgeries, including surgical procedures to correct the refractive error of the eye to get rid of or reduce dependence on glasses and contact lens. The company also provides surgical retinal treatments, corneal transplantation and pinhole pupilloplasty, oculoplasty, and surgeries for the tr... [Read more]

Industry Health Services

Founded 2010

Employees 4,214

Stock Exchange Bombay Stock Exchange

Ticker Symbol 544350

Full Company Profile

Financial Performance

In fiscal year 2026, Dr. Agarwal's Health Care's revenue was 20.80 billion, an increase of 21.57% compared to the previous year's 17.11 billion. Earnings were 1.33 billion, an increase of 59.59%.

Financial Statements

Analyst Summary

According to 5 analysts, the average rating for 544350 stock is "Buy." The 12-month stock price target is ₹545.00, which is an increase of 9.61% from the latest price.

Price Target

₹545.00

(9.61% upside)

Analyst Consensus: Buy

Stock Forecasts